ResearchMoz

Duodenal Ulcer Global Clinical Trials Review, H2, 2012

Publisher Name » GlobalData
Published Date » 2012-08-15
No. Of Pages » 93
Duodenal Ulcer Global Clinical Trials Review, H2, 2012

GlobalData's clinical trial report, Duodenal Ulcer Global Clinical Trials Review, H2, 2012" provides data on the Duodenal Ulcer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Duodenal Ulcer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Duodenal Ulcer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords

Duodenal Ulcer Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Duodenal Ulcer, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5

Introduction 6
Duodenal Ulcer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Duodenal Ulcer 22
Subjects Recruited Over a Period of Time 23
Prominent Sponsors 24
Top Companies Participating in Duodenal Ulcer Therapeutics Clinical Trials 26
Prominent Drug Comparison 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
AstraZeneca PLC 29
Clinical Trial Overview of AstraZeneca PLC 29
Takeda Pharmaceutical Company Limited 30
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 30
Teva Pharmaceuticals USA, Inc. 31
Clinical Trial Overview of Teva Pharmaceuticals USA, Inc. 31
Eisai Inc. 32
Clinical Trial Overview of Eisai Inc. 32
Livzon Pharmaceutical Group Inc. 33
Clinical Trial Overview of Livzon Pharmaceutical Group Inc. 33
Dr. Reddy's Laboratories Limited 34
Clinical Trial Overview of Dr. Reddy's Laboratories Limited 34
Steba Laboratories Ltd. 35
Clinical Trial Overview of Steba Laboratories Ltd. 35
PLx Pharma Inc. 36
Clinical Trial Overview of PLx Pharma Inc. 36
Ranbaxy Laboratories Limited 37
Clinical Trial Overview of Ranbaxy Laboratories Limited 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Merck & Co., Inc. 39
Clinical Trial Overview of Merck & Co., Inc. 39
Perrigo Company 40
Clinical Trial Overview of Perrigo Company 40
Sequella, Inc. 41
Clinical Trial Overview of Sequella, Inc. 41
Clinical Trial Overview of Top Universities / Institutes / Hospitals 42
Hamamatsu University School of Medicine 42
Clinical Trial Overview of Hamamatsu University School of Medicine 42
National Taiwan University Hospital 43
Clinical Trial Overview of National Taiwan University Hospital 43
University of California, San Francisco 44
Clinical Trial Overview of University of California, San Francisco 44
Zagazig University School of Medicine 45
Clinical Trial Overview of Zagazig University School of Medicine 45
Dr Sadi Konuk Research and Training Hospital 46
Clinical Trial Overview of Dr Sadi Konuk Research and Training Hospital 46
Kurdistan University of Medical Sciences 47
Clinical Trial Overview of Kurdistan University of Medical Sciences 47
Keimyung University 48
Clinical Trial Overview of Keimyung University 48
Translational Research Informatics Center 49
Clinical Trial Overview of Translational Research Informatics Center 49
Mashhad University of Medical Sciences 50
Clinical Trial Overview of Mashhad University of Medical Sciences 50
Yonsei University 51
Clinical Trial Overview of Yonsei University 51
Gentofte University Hospital 52
Clinical Trial Overview of Gentofte University Hospital 52
Five Key Clinical Profiles 53

Appendix 90
Abbreviations 90
Definitions 90
Research Methodology 91
Secondary Research 91
About GlobalData 92
Contact Us 92
Disclaimer 92
Source 93

List of Tables

 
Duodenal Ulcer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Duodenal Ulcer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Duodenal Ulcer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Duodenal Ulcer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 10
Duodenal Ulcer Therapeutics Clinical Trials, Europe, Top Countries, 2012* 11
Duodenal Ulcer Therapeutics Clinical Trials, North America, Top Countries, 2012* 12
Duodenal Ulcer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13
Duodenal Ulcer Therapeutics Clinical Trials, BRIC Countries, 2012* 14
Duodenal Ulcer Therapeutics Clinical Trials, G7 Countries, 2012* 15
Duodenal Ulcer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
Duodenal Ulcer Therapeutics Clinical Trials, E7 Countries, 2012* 17
Duodenal Ulcer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18
Duodenal Ulcer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 19
Duodenal Ulcer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 20
Duodenal Ulcer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21
Duodenal Ulcer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 22
Duodenal Ulcer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 23
Duodenal Ulcer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25
Duodenal Ulcer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 27
Duodenal Ulcer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 28
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 29
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012* 30
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceuticals USA, Inc., 2012* 31
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 32
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Livzon Pharmaceutical Group Inc., 2012* 33
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2012* 34
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Steba Laboratories Ltd., 2012* 35
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by PLx Pharma Inc., 2012* 36
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ranbaxy Laboratories Limited, 2012* 37
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 38
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 39
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Perrigo Company, 2012* 40
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sequella, Inc., 2012* 41
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamamatsu University School of Medicine, 2012* 42
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 43
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 44
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Zagazig University School of Medicine, 2012* 45
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr Sadi Konuk Research and Training Hospital, 2012* 46
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kurdistan University of Medical Sciences, 2012* 47
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Keimyung University, 2012* 48
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Translational Research Informatics Center, 2012* 49
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2012* 50
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2012* 51
Duodenal Ulcer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gentofte University Hospital, 2012* 52

List of Figures

List of Figures

Duodenal Ulcer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
Duodenal Ulcer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Duodenal Ulcer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Duodenal Ulcer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 10
Duodenal Ulcer Therapeutics Clinical Trials, Europe, Top Countries (%), 2012* 11
Duodenal Ulcer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12
Duodenal Ulcer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 13
Duodenal Ulcer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 14
Duodenal Ulcer Therapeutics Clinical Trials, G7 Countries (%), 2012* 15
Duodenal Ulcer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
Duodenal Ulcer Therapeutics Clinical Trials, E7 Countries (%), 2012* 17
Duodenal Ulcer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18
Duodenal Ulcer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 19
Duodenal Ulcer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 20
Duodenal Ulcer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21
Duodenal Ulcer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 23
Duodenal Ulcer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24
Duodenal Ulcer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26
Duodenal Ulcer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 28
GlobalData Methodology 91

Upcoming Reports:

Portable Battery Powered Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
The growing demand for portable electronics has led the growth of this market. Earlier, batteries were used for conventional products such as flashlights, watches, calculators etc. Now-a-days the scenario has totally changed and the introduction of portable devices has increased in the areas of communications, entertainment, computing, and photography, thus pushing the market growth.  The application areas of this market include those in lighting, entertainment, medical, science, toys, cameras, computers, navigation, and communication. Battery powered products are...
Dental Devices Market- Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012-2018
By - Transparency Market Research
With improper eating habits and unhealthy food, there is an increase in the incidences of oral diseases across the world. This is one of the major factors driving dental equipments and consumables market. This market is experiencing significant technology developments due to increasing demand of painless dental treatment procedures.  This research report analyzes the dental devices market depending on various segments and major geographies. This detailed study includes trend analysis, market numbers, industry growth drivers and restraints along with the future...
Prefilled Syringes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Prefilled syringes are primary injectable drug delivery devices administered by a medical practitioner or a healthcare provider. These syringes are prefilled with drugs with an appropriate and prescribed amount, and so are ready to be used by the patients directly. Currently, there are over 60 types of drug prefilled syringes available in the market and many more are in product pipelines. Rising incidences of chronic diseases requiring regular drug administration and the rising home healthcare market are the two most influential growth drivers for the prefilled syringes...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...